Talk:John C. Martin (businessman)

Deletions and replacements

This quote from Bloomberg (2014) was deleted as "failing WP:V)" which it doesn't.

• Armstrong, Drew (21 March 2014). "Gilead's $84,000 Treatment Questioned by U.S. Lawmakers". Bloomberg. Retrieved 27 October 2015.

"On one hand, this agent offers up to a 95% response rate as part of an interferon-free treatment regimen for hepatitis C.6 Generally speaking, it is more effective and better tolerated than alternative treatments. Unfortunately, the current per pill cost—$1,000—results in an $84,000 treatment course, creating barriers to therapy for many. Patients, providers, and payors alike have expressed outrage, and the debate has even drawn the attention of the US Congress. Despite these concerns, sofosbuvir rapidly has become a top seller in the United States."

— Bloomberg March 21st, 2014

It was replaced with this quote from Pharmacy Purchasing and Products article which is from February 2015. This quote is promotional. It was added with this summary "restore quote with correct source (it was from Pharmacy Purchasing & Products Magazine); also fix source template)" Pharmacy Purchasing & Products Magazine is not the "correct source;" as it is promotional and was published almost a year after the Bloomberg article was published.

• Lucio, Steven (February 2015). "The Increasing Impact of High-Cost Specialty Therapies". Pharmacy Purchasing & Products Magazine. Retrieved 4 December 2015.

"Sofosbuvir also is an excellent example of both the benefit and the challenge of specialty medications. On one hand, this agent offers up to a 95% response rate as part of an interferon-free treatment regimen for hepatitis C.⁶ Generally speaking, it is more effective and better tolerated than alternative treatments.⁶ Unfortunately, the current per pill cost—$1,000—results in an $84,000 treatment course, creating barriers to therapy for many.⁶ Patients, providers, and payors alike have expressed outrage, and the debate has even drawn the attention of the US Congress.⁷ Despite these concerns, sofosbuvir rapidly has become a top seller in the United States ...."

— 

I will wait for a response and then I will undo the changes. Thanks to fellow volunteer editors for contributing your free time to Wikipedia.Oceanflynn (talk) 21:56, 17 January 2017 (UTC)

External links modified

Hello fellow Wikipedians,

I have just modified 2 external links on John C. Martin (businessman). Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

• Added archive https://web.archive.org/web/20131209052944/http://www.gilead.com/about/leadership/senior-leadership/leadership-bio1 to http://www.gilead.com/about/leadership/senior-leadership/leadership-bio1
• Added archive https://web.archive.org/web/20151208051829/http://www.pppmag.com/article_print.php?articleid=1637 to http://www.pppmag.com/article_print.php?articleid=1637

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

• If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
• If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 08:40, 27 November 2017 (UTC)